CIK 0000894158 · Non-accelerated filer<br>Smaller reporting company
Theriva Biologics, Inc.
Sign in to watch- Ticker
- TOVX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 133808303
- Phone
- (734) 332-7800
- Business address
- 9605 MEDICAL CENTER DRIVE, SUITE 270, ROCKVILLE, MD, 20850
- Former names
- Synthetic Biologics, Inc., ADEONA PHARMACEUTICALS, INC., PIPEX PHARMACEUTICALS, INC., SHEFFIELD PHARMACEUTICALS INC, SHEFFIELD MEDICAL TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 35 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-11-30 | SHALLCROSS STEVEN A Chief Financial Officer | Grant or award · Stock Options | +500,000 | 500,000 | ||
| 2016-11-18 | Tarriff Scott Director | Grant or award | +300,000 | 300,000 | ||
| 2016-11-18 | Tarriff Scott Director | Grant or award · Series A Warrant | +300,000 | 300,000 | ||
| 2016-11-18 | Tarriff Scott Director | Grant or award · Series B Warrant | +300,000 | 300,000 | ||
| 2015-12-04 | Kraws Jeffrey J Director | Grant or award · Stock Options | +125,000 | 125,000 | ||
| 2015-12-04 | Tarriff Scott Director | Grant or award · Stock Options | +125,000 | 125,000 | ||
| 2015-12-04 | Wolf Jeffrey Alan Director | Grant or award · Stock Options | +125,000 | 125,000 | ||
| 2015-12-04 | SHALLCROSS STEVEN A Chief Financial Officer | Grant or award · Stock Options | +100,000 | 100,000 | ||
| 2015-12-04 | Riley Jeffrey Scott Chief Executive Officer | Grant or award · Stock Options | +500,000 | 500,000 | ||
| 2015-09-02 | KIRK RANDAL J 10% owner | Purchase | +937,500 | $3.20 | $3.0M | 9,613,268 |
| 2015-06-01 | SHALLCROSS STEVEN A Chief Financial Officer | Grant or award · Stock Options | +900,000 | 900,000 | ||
| 2015-04-01 | Wolf Jeffrey Alan Director | Option exercise | +10,842 | $0.09 | $976 | 10,842 |
| 2015-04-01 | Wolf Jeffrey Alan Director | Option exercise · Stock Options | −10,842 | 0 | ||
| 2015-01-08 | Ballantyne Charles Evan Chief Financial Officer | Grant or award · Stock Options | +200,000 | 200,000 | ||
| 2015-01-08 | Riley Jeffrey Scott CEO and President | Grant or award · Stock Options | +350,000 | 350,000 | ||
| 2014-05-22 | Ballantyne Charles Evan Chief Financial Officer | Purchase | +10,000 | $1.35 | $14K | 10,000 |
| 2014-04-30 | KANZER STEVE H 10% owner | Sale | −5,003,025 | $1.43 | $7.2M | 2,195,489 |
| 2014-04-29 | KANZER STEVE H 10% owner | Sale | −87,935 | $2.98 | $262K | 6,823,268 |
| 2014-04-28 | KANZER STEVE H 10% owner | Sale | −175,177 | $2.86 | $501K | 6,911,203 |
| 2014-04-17 | Tarriff Scott Director | Grant or award · Stock Options (Right to Buy) | +105,000 | 105,000 |
Page 4 of 6 · 113 trades